TickerFacts.

Outlook Therapeutics, Inc. (OTLK): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2019-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.

$1.08M
As of 2019-09-30
-28.0%
3-year compound annual growth
$2.92M2015-09-30: $2.92M2016-09-30: $2.88M2017-09-30: $203.7K2018-09-30: $165.0K2019-09-30: $1.08M$1.08M
2015-09-30 Long-Term Debt (USD) 2019-09-30
Period endedLong-Term DebtChange YoYSource filing
2019-09-30$1.08M+552.5%2019-12-19, Balance as of period end
2018-09-30$165.0K-19.0%2019-12-19, Balance as of period end
2017-09-30$203.7K-92.9%2017-12-29, Balance as of period end
2016-09-30$2.88M-1.4%2016-12-29, Balance as of period end
2015-09-30$2.92Mn/a2016-12-29, Balance as of period end